ABC | Volume 113, Nº5, Novembro 2019

Artigo Original Congo et al. Fibrilação auricular de novo no IAMSST Arq Bras Cardiol. 2019; 113(5):948-957 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 9. Goldberg R, Yarzebski J, Lessard D, Wu J, Gore JM. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: acommunity-wide perspective. Am Heart J. 2002;143(3):519-27. 10. Rubenstein J, Cinquegrani MP, Wright J. Atrial fibrillation in acute coronary syndrome. J Atr Fibrillation. 2012;5(1):551. 11. KinjoK,SatoH,OhnishiY,HishidaE,NakataniD,MizunoH,etal.Prognostic significance of atrial fibrillation/atrial flutter in patients with acutemyocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2003;92(10):1150-4. 12. Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA. 2011;306(20):2248-54. 13. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESCGuidelines for themanagement of acutemyocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST- segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. 14. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-2962. 15. Lopes RD, Elliott LE, White HD, Hochman JS, Van deWerf F, Ardissino D, et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009;30(16):2019-28. 16. DewildeWJ,OirbansT,VerheugtFW,KelderJC,DeSmetBJ,HerrmanJP,etal. Useofclopidogrelwithorwithoutaspirin inpatientstakingoralanticoagulant therapyandundergoingpercutaneouscoronary intervention:anopen-label, randomised, controlled trial. Lancet. 2013;381(9872):1107-15. 17. Gong X, Tang S, Li J, Zhang X, Tian X, Ma S. Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: a systematic review and network meta-analysis. PLoS One. 2017;12(10):e0186449. 18. Stenestrand U, Lindback J, Wallentin L, RIKS-HIA Registry. Anticoagulation therapy in atrial fibrillation in combinationwith acutemyocardial infarction influences long-termoutcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Circulation. 2005;112(21):3225-31. 19. McMurray J, Kober L, Robertson M, Dargie H, Colucci W, Lopez-Sendon J, et al. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol. 2005;45(4):525-30. 20. PedersonOD, Bagger H, Kober L, Torp-PedersenC. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation. 1999;100(4):376-80. 21. Danchin N, Fauchier L, Marijon E, Barnay C, Furber A, Mabo P, et al. Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register. Heart. 2010;96(22):1809-14. 22. Batra G, Svennblad B, Held C, Jernberg T, Johanson P, Wallentin L, et al. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Heart. 2016;102(12):926-33. 23. Sibley S, Muscedere J. New-onset atrial fibrillation in critically ill patients. Can Respir J. 2015;22(3):179-82. 24. Moss TJ, Calland JF, Enfield KB, Gomez-Manjarres DC, Ruminski C, DiMarco JP, et al. New-onset atrial fibrillation in the critically III. Crit Care Med. 2017;45(5):790-7. 25. Bosch NA, Cimini J, Walkey AJ. Atrial fibrillation in the ICU. Chest. 2018;154(6):1424-34. 26. Wong C-K, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, et al. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial. Card Electrophysiol Rev. 2003;7(3):201-7. 27. Kyriakidis M, Barbetseas J, Antonopoulos A, Skouros C, Tentolouris C, Toutouzas P. Early atrial arrhythmias in acute myocardial infarction. Chest. 1992;101(4):944-7. 28. Tjandrawidjaja MC, Fu Y, Kim DH, Burton JR, Lindholm L, Armstrong PW, et al. Compromised atrial coronary anatomy is associated with atrial arrhythmias and atrioventricular block complicating acute myocardial infarction. J Electrocardiol. 2005;38(3):271-8. 29. Yamashita T, Murakawa Y, Ajiki K, Omata M. Incidence of induced atrial fibrillation/flutter in complete atrioventricular block. A concept of ‘atrial- malfunctioning’ atrio-hisian block. Circulation. 1997;95(3):650-4. 30. Celik T, Iyisoy A, Kursaklioglu H, et al. Effects of primary percutaneous coronary interventiononpwavedispersion.AnnNoninvasiveElectrocardiol. 2005;10(3):342-7. 31. Akdemir R, Ozhan H, Gunduz H, et al. Effect of reperfusion on P-wave duration and P-wave dispersion in acute myocardial infarction: primary angioplasty versus thrombolytic therapy. Ann Noninvasive Electrocardiol. 2005;10(1):35-40. 957